Evidence map›Paper›PMID 40718167›Full record

ArticleCureus2025

Effect of Dietary Intake of Advanced Glycation End Products on Metabolic Parameters and Anthropometric Measurements in Adults.

Ayfer Beyaz Coskun

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ayfer Beyaz CoskunNutrition and Dietetics, Firat University, Elazig, TUR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Advanced glycation end products (AGEs) are exogenously taken up and endogenously secreted. The amount of intake and the level of effect can be affected by dietary interventions and some lifestyle factors.  Methodology This study was conducted with 920 adults aged 18-64 years. The physical activity status of the participants was questioned, anthropometric measurements were taken, and blood biochemical findings were recorded to calculate metabolic syndrome and cardiovascular disease risk. Daily consumption of carboxymethyl lysine, an important type of AGEs, was calculated with a validated semi-quantitative food frequency questionnaire and classified as high, moderate, and low intake levels. Results Those with high AGE consumption ate significantly more at lunch and dinner. It was found that 446 (73.8%) women consumed significantly more AGE (

Indexed as

advanced glycation end productsanthropometric measurementcardiovascular diseasemetabolic parametersmetabolic syndrome

Identifiers

PMID40718167
PMCPMC12296406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.